Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
|
journal
|
July 2021 |
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
SARS-CoV-2 Vaccines: Status Report
|
journal
|
April 2020 |
Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope
|
journal
|
June 2019 |
Structure-Guided Molecular Grafting of a Complex Broadly Neutralizing Viral Epitope
|
journal
|
April 2020 |
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
|
journal
|
October 2020 |
Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021
|
journal
|
August 2021 |
The time course of the immune response to experimental coronavirus infection of man
|
journal
|
October 1990 |
MolProbity : all-atom structure validation for macromolecular crystallography
|
journal
|
December 2009 |
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|
journal
|
March 2021 |
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
|
journal
|
June 2020 |
Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
|
journal
|
February 2021 |
The CCP4 suite programs for protein crystallography
|
journal
|
September 1994 |
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
|
journal
|
March 2021 |
Proof of principle for epitope-focused vaccine design
|
journal
|
February 2014 |
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
|
journal
|
May 2020 |
Structure and Immune Recognition of the HIV Glycan Shield
|
journal
|
May 2018 |
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
|
journal
|
August 2020 |
Disquisitions on Original Antigenic sin
|
journal
|
September 1966 |
Transmission of MERS-Coronavirus in Household Contacts
|
journal
|
August 2014 |
Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
|
journal
|
August 2021 |
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
Scaling and assessment of data quality
|
journal
|
December 2005 |
An introduction to data reduction: space-group determination, scaling and intensity statistics
|
journal
|
March 2011 |
How good are my data and what is the resolution?
|
journal
|
June 2013 |
COVID-19-neutralizing antibodies predict disease severity and survival
|
journal
|
January 2021 |
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
|
journal
|
April 2021 |
Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection
|
journal
|
June 2021 |
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
|
journal
|
June 2020 |
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
|
journal
|
August 2020 |
Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021
|
journal
|
October 2021 |
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
|
journal
|
July 2020 |
SARS‐CoV‐2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination
|
journal
|
October 2020 |
Characterization of Influenza Antibodies by Serum Absorption
|
journal
|
August 1956 |
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
|
journal
|
May 2021 |
Human neutralizing antibodies elicited by SARS-CoV-2 infection
|
journal
|
May 2020 |
Integration, scaling, space-group assignment and post-refinement
|
journal
|
January 2010 |
XDS
|
journal
|
January 2010 |
Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
|
journal
|
October 2020 |
Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates
|
journal
|
January 2021 |
Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation
|
journal
|
April 2014 |
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
|
journal
|
March 2020 |
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
|
journal
|
February 2020 |
Self-Assembling Nanoparticle Vaccines Displaying the Receptor Binding Domain of SARS-CoV-2 Elicit Robust Protective Immune Responses in Rhesus Monkeys
|
journal
|
May 2021 |
Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity
|
journal
|
December 2020 |
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
|
journal
|
November 2020 |
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
|
journal
|
December 2020 |
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
|
journal
|
August 2021 |
A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice
|
journal
|
January 2022 |
Automated electron microscope tomography using robust prediction of specimen movements
|
journal
|
October 2005 |
Phaser crystallographic software
|
journal
|
July 2007 |
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
|
journal
|
November 2015 |
SARS-like WIV1-CoV poised for human emergence
|
journal
|
March 2016 |
The Tecumseh Study of Respiratory Illness. VI. Frequency of and Relationship between Outbreaks of Coronavims Infection
|
journal
|
March 1974 |
Retroviruses Pseudotyped with the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Efficiently Infect Cells Expressing Angiotensin-Converting Enzyme 2
|
journal
|
October 2004 |
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021
|
journal
|
August 2021 |
Elicitation of structure-specific antibodies by epitope scaffolds
|
journal
|
September 2010 |
UCSF Chimera?A visualization system for exploratory research and analysis
|
journal
|
January 2004 |
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
|
journal
|
November 2020 |
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
|
journal
|
May 2020 |
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
|
journal
|
March 2021 |
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
|
journal
|
March 2013 |
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
|
journal
|
February 2021 |
Systematic design and testing of nested (RT-)PCR primers for specific amplification of mouse rearranged/expressed immunoglobulin variable region genes from small number of B cells
|
journal
|
December 2008 |
New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021
|
journal
|
August 2021 |
Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus
|
journal
|
October 2019 |
Lessons for COVID-19 Immunity from Other Coronavirus Infections
|
journal
|
August 2020 |
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
|
journal
|
May 2021 |
RELION: Implementation of a Bayesian approach to cryo-EM structure determination
|
journal
|
December 2012 |
Immunogenic Stimulus for Germline Precursors of Antibodies that Engage the Influenza Hemagglutinin Receptor-Binding Site
|
journal
|
December 2015 |
Viral Receptor-Binding Site Antibodies with Diverse Germline Origins
|
journal
|
May 2015 |
Rises in Titers of Antibody to Human Corona Viruses oc43 and 229e in Seattle Families During 1975–1979
|
journal
|
May 1986 |
Structural basis of receptor recognition by SARS-CoV-2
|
journal
|
March 2020 |
Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses
|
journal
|
October 2021 |
Affordable Luciferase Reporter Assay for Cell-Based High-Throughput Screening
|
journal
|
April 2013 |
Immunosilencing a Highly Immunogenic Protein Trimerization Domain
|
journal
|
January 2015 |
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
|
journal
|
April 2021 |
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
|
journal
|
April 2021 |
Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard
|
journal
|
December 2007 |
Cloning and expression of murine Ig genes from single B cells
|
journal
|
October 2009 |
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike
|
journal
|
September 2021 |
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
|
journal
|
November 2020 |
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
|
journal
|
October 2021 |
Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice
|
journal
|
February 2021 |
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
|
journal
|
February 2021 |
In vitro reconstitution of B cell receptor–antigen interactions to evaluate potential vaccine candidates
|
journal
|
January 2016 |
Broad neutralization of SARS-related viruses by human monoclonal antibodies
|
journal
|
June 2020 |
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
|
journal
|
March 2021 |
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
|
journal
|
August 2020 |
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|
journal
|
February 2020 |
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine
|
journal
|
April 2021 |
Duration of Antibody Responses after Severe Acute Respiratory Syndrome
|
journal
|
October 2007 |
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody
|
journal
|
December 2020 |
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
|
journal
|
May 2020 |
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
|
journal
|
July 2020 |
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
|
journal
|
August 2021 |
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
|
journal
|
April 2020 |
Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin
|
journal
|
February 2012 |
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|
journal
|
April 2021 |